Valziflocept (BAX1810, TAK-752) is a recombinant soluble human FcgammaRIIb receptor that targets Fc and FcgammaR. FcgammaRs bind and neutralize pathogenic IgG, thus forming a decoy or scavenger receptor that can reduce the severity of autoimmune diseases. Valziflocept can be used in studies of autoimmune diseases such as systemic lupus erythematosus (SLE)[1].
Molecular Weight:
(19.693 kDa)
Purity:
99.00
CAS Number:
[1804910-11-9]
Target:
Fc Receptor (FcR)
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
